Long Feng

893 total citations
44 papers, 360 citations indexed

About

Long Feng is a scholar working on Molecular Biology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Long Feng has authored 44 papers receiving a total of 360 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Molecular Biology, 15 papers in Oncology and 11 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Long Feng's work include MicroRNA in disease regulation (4 papers), Cancer Cells and Metastasis (4 papers) and Cholangiocarcinoma and Gallbladder Cancer Studies (4 papers). Long Feng is often cited by papers focused on MicroRNA in disease regulation (4 papers), Cancer Cells and Metastasis (4 papers) and Cholangiocarcinoma and Gallbladder Cancer Studies (4 papers). Long Feng collaborates with scholars based in China, Hong Kong and Czechia. Long Feng's co-authors include Jun Wan, Fengming Yi, Jian Tian, Yupeng Liu, Wei Luo, Kanghua Li, Liang Chen, Yupeng Liu, Chenghong Yin and Ying Wang and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Long Feng

38 papers receiving 354 citations

Peers

Long Feng
Zhi Xu China
Sandipto Sarkar United States
Che-Chia Hsu United States
Long Feng
Citations per year, relative to Long Feng Long Feng (= 1×) peers Zhangwei Tong

Countries citing papers authored by Long Feng

Since Specialization
Citations

This map shows the geographic impact of Long Feng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Long Feng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Long Feng more than expected).

Fields of papers citing papers by Long Feng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Long Feng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Long Feng. The network helps show where Long Feng may publish in the future.

Co-authorship network of co-authors of Long Feng

This figure shows the co-authorship network connecting the top 25 collaborators of Long Feng. A scholar is included among the top collaborators of Long Feng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Long Feng. Long Feng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chen, Meng, Hao Yang, Shengli Li, et al.. (2025). Vicenin-2 reduces inflammation and apoptosis to relieve skin photoaging via suppressing GSK3β. Journal of Photochemistry and Photobiology B Biology. 264. 113117–113117. 3 indexed citations
2.
Lu, Yanju, Junming Xu, Jingjing Shi, et al.. (2025). Developing multifunctional PtCo/γ-MnO₂@C catalyst for efficient electrocatalytic cleavage of lignin dimers C -O-4 bonds. Chemical Engineering Journal. 520. 166329–166329.
3.
Sun, Ying, Mei Xue, Long Feng, et al.. (2025). Cinobufagin Inhibits Invasion and Migration of Non-Small Cell Lung Cancer via Regulating Glucose Metabolism Reprogramming in Tumor-Associated Macrophages. Drug Design Development and Therapy. Volume 19. 6647–6664. 1 indexed citations
4.
Li, Gege, et al.. (2024). Design and evaluation of mRNA encoding recombinant neutralizing antibodies for botulinum neurotoxin type B intoxication prophylaxis. Human Vaccines & Immunotherapeutics. 20(1). 2358570–2358570. 3 indexed citations
5.
Li, Qing, Hongmei Lü, Yongdui Ruan, et al.. (2024). Andrographolide suppresses SARS-CoV-2 infection by downregulating ACE2 expression: A mechanistic study. Antiviral Therapy. 29(3). 221985712–221985712. 2 indexed citations
6.
Ying, Sun, Long Feng, Jianfeng Gao, et al.. (2024). Cinobufagin inhibits M2‑like tumor‑associated macrophage polarization to attenuate the invasion and migration of lung cancer cells. International Journal of Oncology. 65(5). 6 indexed citations
7.
Feng, Long, et al.. (2023). Efficacy and Safety of Drug-Eluting Bead TACE in the Treatment of Primary or Secondary Liver Cancer. Canadian Journal of Gastroenterology and Hepatology. 2023. 1–8. 4 indexed citations
8.
Liu, Qing, et al.. (2023). Biological reconstruction of bone defect after resection of malignant bone tumor by allograft: a single-center retrospective cohort study. World Journal of Surgical Oncology. 21(1). 234–234. 4 indexed citations
10.
Yi, Fengming, Wei Zhang, & Long Feng. (2022). Efficacy and safety of different options for liver regeneration of future liver remnant in patients with liver malignancies: a systematic review and network meta-analysis. World Journal of Surgical Oncology. 20(1). 399–399. 7 indexed citations
11.
Zhang, Can, et al.. (2022). METTL3 upregulates COPS5 expression in osteosarcoma in an m6A-related manner to promote osteosarcoma progression. Experimental Cell Research. 420(2). 113353–113353. 9 indexed citations
12.
Yi, Fengming, et al.. (2021). Potential mechanism of circRNA_000585 in cholangiocarcinoma. Journal of International Medical Research. 49(6). 3619085429–3619085429. 8 indexed citations
13.
14.
Liu, Yupeng, et al.. (2020). <p>circPVT1 Facilitates Invasion and Metastasis by Regulating miR-205-5p/c-FLIP Axis in Osteosarcoma</p>. Cancer Management and Research. Volume 12. 1229–1240. 28 indexed citations
15.
16.
Yu, Xiaoyan, Long Feng, Xiaopeng Yang, et al.. (2018). A novel fully human anti-CD47 antibody as a potential therapy for human neoplasms with good safety. Biochimie. 151. 54–66. 14 indexed citations
17.
Feng, Long, Yunyun Ma, Ping Li, et al.. (2016). miR-15a induces cell apoptosis by targeting BCL2L2 and BCL2 in HPV-positive hypopharyngeal squamous cell carcinoma. Oncology Reports. 36(4). 2169–2176. 18 indexed citations
18.
Wang, Ying, et al.. (2015). Ara-C and anti-CD47 antibody combination therapy eliminates acute monocytic leukemia THP-1 cells in vivo and in vitro. Genetics and Molecular Research. 14(2). 5630–5641. 23 indexed citations
19.
Zhou, Weihua, Caifeng Yue, Jie Xu, et al.. (2013). Autophagic Protein Beclin 1 Serves as an Independent Positive Prognostic Biomarker for Non-Small Cell Lung Cancer. PLoS ONE. 8(11). e80338–e80338. 34 indexed citations
20.
Feng, Long. (2007). Comparison of Raltitrexed Plus Oxaliplatinl and 5-Fluorouracil/Leucovorin Plus Oxaliplatinl in Treatment of Advanced Colorectal Carcinoma. Zhongliu fangzhi yanjiu. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026